NDC 11523-7157-07 - Claritin Reditabs
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11523-7157
- Requested NDC
- 11523-7157-07
- Package NDCs from labels
- 11523-7157-2, 11523-7157-3, 11523-7157-4, 11523-7157-7, 11523-7157-8, 11523-7157-9, 11523-7157-07
- Manufacturer
- Bayer Healthcare LLC.
- Effective date
- 2025-12-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Claritin ® RediTabs ® | Bayer Healthcare LLC. | 2025-12-05 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-7157-2 | ClaritinReditabs | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 12 | |
| 11523-7157-2 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-3 | ClaritinReditabs | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 12 | |
| 11523-7157-3 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-4 | ClaritinReditabs | 2 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 2 | 12 | |
| 11523-7157-4 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-7 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-7 | ClaritinReditabs | 4 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 4 | 12 | |
| 11523-7157-8 | ClaritinReditabs | 5 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 5 | 12 | |
| 11523-7157-8 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-9 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-9 | ClaritinReditabs | 7 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 7 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11523-7157 | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [BAYER HEALTHCARE LLC.] | 11 | Current NDC, Legacy NDC, 12 package rows | 20241208_b681ea25-d00b-4c8a-8054-cc6f983ce337.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-7157-2 | EA - Each | 11523-7157 | 128f54a2-0776-4dea-a042-44b6442d3b69 | 1 | 2012-07-24 |
| 11523-7157-3 | EA - Each | 11523-7157 | fd89b497-47a4-4038-a766-17f963a2870b | 1 | 2012-07-24 |
| 11523-7157-8 | EA - Each | 11523-7157 | a461ab26-b1e4-4ea2-86d4-61841d1b15a0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Loratadine | ACTIVE INGREDIENT | 7AJO3BO7QN | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| Loratadine | ACTIVE MOIETY | 7AJO3BO7QN | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| good sense childrens allergy relief | LORATADINE | L. Perrigo Company | 643dfe16-9cd1-47bb-8bce-303e6885c644 | 2026-04-20 | Warnings | 7AJO3BO7QN |
| Loratadine 10mg | LORATADINE | BETTER LIVING BRANDS, LLC | 46d615dd-45d5-2dfc-e063-6394a90a5d42 | 2026-04-18 | Warnings | 7AJO3BO7QN |
| All Day Allergy Relief | LORATADINE | WALMART INC. (see also Equate) | 80958503-400c-422a-a641-e1a3d5a9a6a8 | 2026-04-17 | Warnings | 7AJO3BO7QN |
| CLENPIQ | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | Ferring Pharmaceuticals Inc. | e95fff66-4ec0-4001-a727-33e66a5ec7d5 | 2026-04-15 | Warnings, Adverse reactions | XF417D3PSL |
| Loratadine | LORATADINE | Camber Consumer Care Inc | 4dec6d48-78e0-48a4-9274-25f6cbf26a2c | 2026-04-10 | Warnings | 7AJO3BO7QN |
| allergy relief d 12 | LORATADINE, PSEUDOEPHEDRINE SULFATE | Walgreen Company | 7e6ea563-cc79-4683-b600-0691e0fb78ab | 2026-04-09 | Warnings | 7AJO3BO7QN |
| Childrens Loratadine | LORATADINE | Sun Pharmaceutical Industries, Inc. | 78e11f1c-c8a4-4b2a-b7dc-ae1b2dea26d0 | 2026-04-08 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | NuCare Pharmaceuticals,Inc. | 16f00a3a-0777-f70c-e063-6294a90a71c9 | 2026-04-06 | Warnings | 7AJO3BO7QN |
| ALLERGY RELIEF 10 mg | LORATADINE | TWIN MED LLC | d943f548-aa0d-4476-e053-2a95a90a7bd4 | 2026-04-01 | Warnings | 7AJO3BO7QN |
| ALLERGY RELIEF | LORATADINE | CARDINAL HEALTH 110, LLC. DBA LEADER | 052e0ea2-441f-42cc-b62c-f2574f995bff | 2026-03-31 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Safecor Health, LLC | 14d1ecf5-d694-4ce0-87e4-df27f3f4d909 | 2026-03-31 | Warnings | 7AJO3BO7QN |
| LORATADINE | LORATADINE | CVS HEALTH CORP | 899800a7-89bc-4a39-88b0-f19d78934daf | 2026-03-26 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | CVS Pharmacy, Inc. | 3937f769-e8e2-4b32-8338-21b0a74a8697 | 2026-03-20 | Warnings | 7AJO3BO7QN |
| Loratadine Allergy Relief | LORATADINE | PD-Rx Pharmaceuticals, Inc. | 7127b39d-3686-4249-b720-43c02b4c4654 | 2026-03-19 | Warnings | 7AJO3BO7QN |
| Childrens Loratadine Oral | LORATADINE | A-S Medication Solutions | 0a42baae-554b-4b93-8780-fe45c42fabc0 | 2026-03-18 | Warnings | 7AJO3BO7QN |
| CHILDRENS ALLERGY RELIEF | LORATADINE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 0e84571d-87b6-4742-ac62-9ed68a115c72 | 2026-03-17 | Warnings | 7AJO3BO7QN |
| allergy relief d 12 | LORATADINE, PSEUDOEPHEDRINE SULFATE | CVS Pharmacy | 0ca2b074-7137-478c-b32c-67f834f6c454 | 2026-03-15 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | NuCare Pharmaceuticals,Inc. | c0e3057d-2dd2-de2b-e053-2995a90a1a1d | 2026-03-05 | Warnings | 7AJO3BO7QN |
| Allergy Relief D | LORATADINE, PSEUDOEPHEDRINE SULFATE | Walgreen Company | 9952e0fb-b20e-4f9c-8be7-aa286e271fee | 2026-02-28 | Warnings | 7AJO3BO7QN |
| Loratadine antihistamine | LORATADINE | PD-Rx Pharmaceuticals, Inc. | 039f144b-891b-4ab0-e063-6394a90aa4c8 | 2026-02-26 | Warnings | 7AJO3BO7QN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.